Oct. 30, 2009 (PR Newswire) --
SUNNYVALE, Calif., Oct. 30 /PRNewswire-FirstCall/ -- Accuray Incorporated (Nasdaq: ARAY), a global leader in the field of radiosurgery, announced today that 28 CyberKnife-focused abstracts have been accepted as part of the 51st Annual Meeting of the American Society for Radiation Oncology (ASTRO), taking place November 1 - 5 in Chicago, Illinois. This represents a 27 percent increase in CyberKnife abstracts over last year's Annual Meeting.
The accepted abstracts, which will be presented as posters or oral presentations, focus on the use of the CyberKnife® Robotic Radiosurgery System to treat tumors located throughout the body including the prostate, lung, brain, spine, liver, pancreas, head and neck.
"The depth and breadth of research presented at this year's ASTRO meeting is a testament to the growing clinical acceptance of the CyberKnife System and the important role it is playing in the treatment of cancer," said Euan Thomson, Ph.D., president and CEO of Accuray.
Highlights of the research that will be showcased include seven presentations focusing on the use of CyberKnife radiosurgery to treat prostate cancer. CyberKnife prostate procedures from July-September 2009 increased 21 percent over the same period the previous year, confirming the increasing demand for this treatment option. To date, CyberKnife radiosurgery has been used to treat more than 4,000 men with prostate cancer.
Additionally, Accuray will host a number of presentations in the company's booth (#1526) reporting on experience with CyberKnife radiosurgery. Presenters include Eric Lartigau, M.D., Ph.D., from Centre Oscar Lambret; Xiaodong Wu, Ph.D., from University of Miami; Donald B. Fuller, M.D., from CyberKnife Centers of San Diego; Brian T. Collins, M.D., from Georgetown University Hospital; Joe Y. Chang, M.D., Ph.D., from M. D. Anderson Cancer Center; Debra Freeman, M.D., from Naples Radiation Oncology; Sonja Dieterich, Ph.D., and Iris Gibbs, M.D., from Stanford University Hospital; Kim Huang, M.D., from University of California San Francisco; and Greg Spurlock from US Radiosurgery.
Accuray will be exhibiting at booth #1526. For more information on the accepted abstracts, posters and in-booth presentations related to the CyberKnife System please visit www.accuraychicago.com.
About the CyberKnife® Robotic Radiosurgery System
The CyberKnife Robotic Radiosurgery System is the world's only robotic radiosurgery system designed to treat tumors anywhere in the body non-invasively. Using continual image guidance technology and computer controlled robotic mobility, the CyberKnife System automatically tracks, detects and corrects for tumor and patient movement in real-time throughout the treatment.
